Form 4: Aspira Women's Health Director Converts Restricted Stock Units to Common Shares

Ellen O'Connor Vos, a Director at Aspira Women's Health Inc., has converted 5,312 restricted stock units (RSUs) into common stock following their vesting on June 4, 2025.

Summary

• Ellen O'Connor Vos, a Director of Aspira Women's Health Inc. (AWHL), reported a change in beneficial ownership via a Form 4 filing.
• On June 4, 2025, 5,312 restricted stock units (RSUs) granted on August 22, 2024, vested and were converted into an equal number of common shares.
• The conversion price for these RSUs was $0, as it represents the vesting of previously granted equity compensation.
• Following this transaction, Ms. Vos beneficially owns 73,989 shares of Aspira Women's Health Inc. common stock.
• The original grant on August 22, 2024, comprised 21,250 RSUs, with 5,312 vesting on this date.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as it reflects a standard, expected equity compensation event for a director, aligning their interests with shareholders. There are no negative implications for the company's operations or financial health reported in this filing.

Positives

• The vesting of restricted stock units aligns the interests of the director with those of the shareholders, as their compensation becomes tied to the company's stock performance.
• The transaction represents a standard, pre-scheduled equity compensation event, indicating continuity in the company's compensation practices.

Future Outlook

This document does not provide any forward-looking statements or guidance regarding the company's financial performance or strategic direction. It solely reports an insider's equity transaction.

Industry Context

This Form 4 filing details a routine insider transaction involving the vesting and conversion of restricted stock units, a common form of equity compensation for directors and executives across various industries. It does not provide insights into broader industry trends or competitive dynamics.

Related Party Transactions

• The transaction involves the conversion of restricted stock units granted to a director, which is a form of equity compensation and a routine related-party transaction.

Stakeholder Impact

• Shareholders: The conversion of RSUs into common stock results in a minor increase in the outstanding share count, leading to slight dilution. However, this is a standard and expected part of equity compensation plans.

Key Dates

Keywords

Aspira Women's Health, AWHL, Form 4, Insider Transaction, Restricted Stock Units, RSU, Beneficial Ownership, Director Compensation, Equity Compensation